All Stories

  1. Identifying and blocking an escape mechanism that brain cancer cells use to evade current therapies
  2. Impact of previous stroke on outcome after thrombectomy in patients with large vessel occlusion
  3. Intracranial pressure monitoring following decompressive hemicraniectomy for malignant cerebral infarction
  4. Endovascular thrombectomy and stenting in the management of carotid fibromuscular dysplasia presenting with major ischemic stroke
  5. Is vascular imaging valuable prior to administration of intravenous tissue plasminogen activator?
  6. Diffusion-weighted Imaging at b1000 for Identifying Intracerebral Hemorrhage: Preliminary Sensitivity, Specificity, and Inter-rater Variability
  7. Short Term Morphine Exposure In Vitro Alters Proliferation and Differentiation of Neural Progenitor Cells and Promotes Apoptosis via Mu Receptors
  8. Should DWI MRI Be the Primary Screening Test for Stroke?
  9. Delayed complications after flow-diverter stenting: Reactive in-stent stenosis and creeping stents
  10. Efficacy of NeuroFlo Device in Treatment of Patients with Atrial Fibrillation
  11. Pharyngo-occipital artery variant arising proximal to occluded internal carotid artery: The risk of an unnecessary endarterectomy
  12. Occlusion Site Does Not Impact Outcome in Patients with Carotid Stroke Undergoing Endovascular Reperfusion
  13. Implementing novel imaging methods for improved diagnosis of disorder of consciousness patients
  14. Revascularization-Outcome Paradox: Not Only Time and Collaterals Status, but Also Complete Recanalization Contribute to Good Neurological Outcome
  15. Excellent rates of recanalization and good functional outcome after stent-based thrombectomy for acute middle cerebral artery occlusion. Is it time for a paradigm shift?
  16. New Strategies for Endovascular Recanalization of Acute Ischemic Stroke
  17. N-arachidonoyl-L-serine (AraS) Possesses Proneurogenic Properties in Vitro and in Vivo after Traumatic Brain Injury
  18. Use of DWI-only MR protocol for screening stroke mimics
  19. Adjuvant use of self-expanding stents in acute atherothrombotic vertebrobasilar occlusions
  20. Incidence of DWI-positive stroke in patients with vertigo of unclear etiology, preliminary results
  21. Clinical relevance of negative initial angiogram in spontaneous subarachnoid hemorrhage
  22. Isolated cortical vein thrombosis: a rare cause of venous stroke with good prognosis after timely diagnosis and treatment
  23. Spinal ischemic stroke following dialysis: clinical and radiologic findings
  24. The Role of Platelets and their Microparticles in Rehabilitation of Ischemic Brain Tissue
  25. Capsular warning syndrome and crescendo lacunar strokes after atherosclerotic stenosis of the recurrent artery of Heubner
  26. Ventriculoperitoneal shunt for intracranial hypertension in cryptococcal meningitis without hydrocephalus
  27. Platelet Microparticles Induce Angiogenesis and Neurogenesis after Cerebral Ischemia
  28. Stroke Complicating Transcatheter Aortic Valve Implantation: Incidence, Risk Factors and Outcome
  29. A reappraisal of the common carotid artery as an access site in interventional procedures for acute stroke therapies
  30. Platelet Microparticles Promote Neural Stem Cell Proliferation, Survival and Differentiation
  31. The Anti-Inflammatory Drug Carprofen Improves Long-Term Outcome and Induces Gliogenesis after Traumatic Brain Injury
  32. Combination of Vascular Endothelial and Fibroblast Growth Factor 2 for Induction of Neurogenesis and Angiogenesis after Traumatic Brain Injury
  33. Recanalization with stent-based mechanical thrombectomy in anterior circulation major ischemic stroke
  34. Effects of Age on Outcome in the SENTIS Trial: Better Outcomes in Elderly Patients
  35. Stent-based mechanical thrombectomy in acute basilar artery occlusion
  36. Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic stroke
  37. N-Arachidonoyl-l-Serine is Neuroprotective after Traumatic Brain Injury by Reducing Apoptosis
  38. Stent for temporary endovascular bypass and thrombectomy in major ischemic stroke
  39. Bone Marrow-Derived Nonreactive Astrocytes in the Mouse Brain After Permanent Middle Cerebral Artery Occlusion
  40. State-of-the-art reperfusion strategies for acute ischemic stroke
  41. Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic stroke
  42. Internal carotid artery agenesis: diagnosis, clinical spectrum, associated conditions and its importance in the era of stroke interventions
  43. Decompressive hemicraniectomy improves outcome in patients with failed arterial recanalization after acute carotid artery occlusion
  44. Thrombosis of non-giant unruptured aneurysms causing ischemic stroke
  45. Prior use of angiotensin-converting enzyme inhibitors does not affect outcome in patients with intracerebral hemorrhage
  46. Endovascular reperfusion therapy for acute ischemic stroke: a meta-analysis
  47. Poster 442: Rehabilitation Outcomes of Stroke Patients Treated With Thrombolysis
  48. Rehabilitation Outcomes of Stroke Patients Treated With Tissue Plasminogen Activator
  49. A new management approach for dental treatment after a cerebrovascular event: a comparative retrospective study
  50. Leptin Reduces Infarct Size in Association with Enhanced Expression of CB2, TRPV1, SIRT-1 and Leptin Receptor
  51. Recanalization of symptomatic carotid artery dissections causing occlusion with multiple stents: the use of delayed double-contrast road map
  52. Therapeutic modalities in symptomatic intracranial arterial occlusive disease
  53. Vascular Endothelial Growth Factor Increases Neurogenesis after Traumatic Brain Injury
  54. Neural and Non-Neural Stem Cells as Novel Therapeutic Modalities for Brain Injury
  55. Penumbra and reperfusion in acute ischaemic stroke: what’s in a name?
  56. Growth factors improve neurogenesis and outcome after focal cerebral ischemia
  57. MULTIMODAL REPERFUSION THERAPY IN PATIENTS WITH ACUTE BASILAR ARTERY OCCLUSION
  58. Fate and manipulations of endogenous neural stem cells following brain ischemia
  59. PRIMARY PROGRESSIVE APHASIA: QUANTITATIVE ANALYSIS
  60. Natural Course and Pathogenesis of Transient Focal Neurologic Symptoms During Pregnancy
  61. Sensitive detection of GFP utilizing tyramide signal amplification to overcome gene silencing
  62. Notch signalling regulates stem cell numbers in vitro and in vivo
  63. Manipulation of Endogenous Neural Stem Cells Following Ischemic Brain Injury
  64. Stroke Complicating Systemic Immune Mediated Disorders
  65. Using Endogenous Neural Stem Cells to Enhance Recovery from Ischemic Brain Injury
  66. Drug-Induced Hypothermia Reduces Ischemic Damage
  67. Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia
  68. Cerebral ischemia and trauma—different etiologies yet similar mechanisms: neuroprotective opportunities
  69. Experimental Models of Head Trauma
  70. Experimental Models in Focal Cerebral Ischemia: Are we there yet?
  71. Expression of endothelial nitric oxide synthase in the ischemic penumbra: relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor
  72. Headache characteristics in patients after migrainous stroke
  73. Re: Cost and Outcome of Mechanical Ventilation for Life-Threatening Stroke
  74. Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia
  75. Prognostic factors in artificially ventilated stroke patients
  76. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis
  77. Transcranial Doppler patterns in patients with anticardiolipin antibodies
  78. Activation of the Adrenocortical Axis by Surgical Stress: Involvement of Central Norepinephrine and Interleukin-1
  79. Features of dural sinus thrombosis simulating pseudotumor cerebri
  80. Unidirectional dyslexia in a polyglot
  81. Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia
  82. Subacute painful lumbosacral polyradiculoneuropathy in immunocompromised patients
  83. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity?
  84. Anticardiolipin Antibodies Are Frequently Present in Patients With Idiopathic Intracranial Hypertension
  85. Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma
  86. Vincristine-induced paralytic ileus in Parkinson's disease
  87. Atypical White Matter Changes in Alzheimer’s Disease
  88. Microsomatoagnosia: whole body schema illusion as part of an epileptic aura
  89. Correspondence
  90. Ornithodoros tholozani bites: A unique clinical picture
  91. In vivo models of traumatic brain injury